Updates in HR-MDS and AML


IDH Inhibitors in MDS: Frequency & Prognosis, Mutations, Therapy Outcomes, Enasidenib/Ivosidenib, HMA Combinations, Options for Clonal Escape

415 views
April 7, 2021
Comments 0
Login to view comments. Click here to Login